The Visual Evoked Potential in Idiopathic Inflammatory Demyelinating Diseases by Neto, Silvio Pessanha et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 5
The Visual Evoked Potential in Idiopathic Inflammatory
Demyelinating Diseases
Silvio Pessanha Neto, Luiz Carlos Pinto and
Regina Maria Papais Alvarenga
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.69311
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
The Visual Evoked Potential in Idiopathic Inflammatory 
Demyelinating Diseas s
Silvio Pessanha Neto, Luiz Carlos Pinto and 
Regina Maria Papais Alvarenga
Additional information is available at the end of the chapter
Abstract
Within the group of inflammatory idiopathic demyelinating diseases, there is a great 
number of diseases that have an initial attack in common, including visual. Multiple 
sclerosis (MS) is a chronic, demyelinating, immune‐mediated disease, with considerably 
varying prevalence and incidence. Neuromyelitis optica (NMO), which until recently 
was considered a variant of MS, is currently considered an independent entity. However, 
it resembles MS, because it is an immune‐mediated disease characterized by the simul‐
taneous or sequential involvement in time of optic neuritis and extensive demyelinating 
myelitis. Fifty percent of patients with MS have isolated optic neuritis. However, the 
frequency of abnormalities ranges from 57 to 100% in visual evoked potential (VEP). 
Several studies have evaluated the clinical, evolutive, and demographic characteristics 
of idiopathic optic neuritis and demonstrated their differences among the cases related 
to MS and NMO. The most common changes in VEP studies in multiple sclerosis are as 
follows: increased interocular differential latency of P100 wave and the absolute increase 
in latency of P100 wave. New studies indicate that VEP pattern in NOM spectrum syn‐
dromes is different from that of MS.
Keywords: neuromyelitis optica, visual evoked potential, optic neuritis, multiple sclerosis, 
P100 wave
1. Introduction
Visual evoked potential (VEP), which has been known for more than 40 years, consists of elec‐
tric signals mainly generated by the occipital cortex in response to visual stimulation. They 
are generally used to assist in the identification of pathologies that impair the visual pathways 
in any of its segments.
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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distribution, and reproduction in any medium, provided the original work is properly cited.
2. Technical aspects
2.1. Stimulation
In VEP studies, two types of stimulation, photostimulators and pattern reversal, are nor‐
mally used. The most used photostimulators are the common photographic flash and 
goggles, which are used for swimming, or similar ones, in which each lens is replaced 
by a cloudy plate, with minute light bulbs installed in its internal face, for the luminous 
extremities to face each eye. These stimulators are connected and synchronized with the 
equipment system of stimulation, scanning, and promediation. Flash stimulation is not 
only the oldest one, used in clinical neurophysiology since the 40s, but also the most com‐
mon method used during many years and until the beginning of the 70s to obtain VEP. The 
flash stimulates almost all the retina, mainly the peripheral one, because of its capacity to 
capture the variations of room luminosity. Depolarization waves provoked by stimuli radi‐
ate mainly to the pretectal zones and thalamic nuclei, ending up in lesser amount in the 
visual cortex, and in larger amount in the association areas, on the nonvisual cortex. When 
the flash is used, it is necessary that the contralateral eye is very well occluded, because 
the capture of potentials generated by the stimulation of the unexamined side can lead to 
false‐negative results.
One of the main disadvantages in the responses obtained with this technique is its great vari‐
ability, both among individuals and in the same patient; it can also vary according to the 
electroencephalographic activity at that moment. Therefore, flash stimulation was gradually 
replaced by more reliable methods, being reserved for the cases of patients with very low 
visual acuity, encephalopathies, and other pathologies.
In the case of goggles, the light bulbs or light emitting diodes (LEDs) on them are generally red, 
and each one has 3 mm of diameter. At each series of stimuli, the stimulator is adjusted so that 
one side of the goggles remains with the light off, occluding vision in one of the patient’s eyes, 
while in the stimulated side the LEDs are on and are turned off with a frequency of 1–2 Hz. In 
each side, at least two series of 60–260 stimuli are applied.
Both flash and goggles stimulate the entire retina and provide results that are more qualita‐
tive than quantitative. However, they are very useful, because they can stimulate the retina 
even when the eyes are closed, as it occurs in the case of patients in coma, children or adults 
who do not want to cooperate [1, 2].
Currently, despite the utility of the photostimulators, the most commonly used visual stimu‐
lation is the pattern reversal that, as already mentioned, consists of a monitor in the screen of 
which there is an image with black and white squares, similar to a chessboard. During stimu‐
lation, the squares alternate their colors. The white ones become black, and the black ones 
become white, successively, at a frequency of 1–2 Hz. These constant inversions stimulate the 
macular area of the retina, more specifically the foveal zone, radiating to the lateral geniculate 
body, and then to the primary visual cortex, in area 17. However, for this, it is important that 
the patient keeps the look fixed on the center of the monitor screen [3].
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In the stimulation by the reversal pattern, the patient should remain seated in front of the 
monitor, with the eyes keeping a distance of 70 cm to 1 m from the screen. As the stimulation 
is monocular, the contralateral eye is kept occluded and at least two series of 60–260 stimuli 
in each side of the visual pathway are applied.
The distance between the patient’s eye and the monitor, related to the size of the each reversal 
pattern square side, provides the visual angle used in the test. Despite the existence of tables, 
the simplest way to calculate the visual angle is to multiply the width of the square by 3450 
and divide the result by the distance in millimeters between the screen and the patient’s eyes. 
This way, the visual angle is obtained in minutes. To convert this unit to degrees, we simply 
divide the resulting value by 60 [4–6].
The visual angle used is very important, because it influences in the exam results. In adults, 
visual angles with 10–20 arcmin produce responses of higher amplitude. The visual angles 
of more than 15 min stimulate mainly the fovea, and those with more than 40 min stimulate 
more the parafoveal retina. The central visual field is the most responsible for P100 ampli‐
tude, because the central vision has greater cortical representation than the peripheral vision. 
Problems in the central vision can change P100 amplitude without modifying its latency. In 
the diagnostic routine, angles of 28–32 arcmin are more frequently used.
The equipment visual stimulation module allows the use of a reversal pattern, the squares 
of which can vary in size according to the examiner interest. In practice, they have options 
of squares of 0.5, 1.0, 2.0, or 5 cm of side. With this, depending on the clinical case and the 
patient’s visual acuity, the series of stimuli can be repeated with the use of different visual 
angles.
There is a direct relation between the visual angle and the exam result. The smaller the 
squares, the more reliable the responses. However, in the patients with visual acuity deficit, 
the use of bigger squares is necessary, because even losing some precision, it is crucial that 
the patient visualizes and identifies the reversal pattern; otherwise, it will not be possible to 
capture responses, or falsely abnormal responses will be obtained [7–9]. Before undergoing 
a VEP study, the patient should have an ophthalmologic evaluation for measuring his/her 
visual acuity, aiming to rule out refractive defects [10].
The reversal pattern can be one of “full field,” which is the most used, or of “half field.” In the 
half‐field pattern, the chessboard image fills only one of the halves of the monitor screen, with 
the other remaining entirely black. This allows selective stimulation of the nasal or temporal 
field of the retinas, serving both for the diagnosis and to inform if the lesion is prechiasmatic, 
chiasmatic, or retrochiasmatic [11].
Some authors have used colored reversal patterns, but the results have not been advanta‐
geous. There is also the “bar grating reversal pattern,” known as gratings, which is little used 
and on which, instead of the squares, the monitor presents horizontal or vertical, white and 
black bars, which alternate colors consecutively too [12, 13].
In brief, because of its higher precision and sensitivity, the reversal pattern is the most com‐
monly used. The flash and goggles are used in cases where it is supposed that the patient 
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is not looking at the center of the screen, in comatose patients, in surgical monitoring, or in 
children who have difficulty fixing attention on the monitor.
2.2. Capture
The most common assembly consists of the colocation of an active electrode in Oz, on the 
occipital cortex, with the reference in Fz, and the ground in the frontal area in Fpz. However, 
depending on the number of channels available, other assemblies can be made. In a second 
channel, for example, the active on Oz can be used, with the reference on Pz or Cz. Although 
being a capture type that is more used in half‐field stimulations, the active electrodes can be 
fixed on points located 5 and 10 cm lateral to Oz, in known leads, such as R5, R10, L5, or L10, 
in which the letters “R” and “L” represent the right side and the left side, respectively.
The visual response is formed by three waves, which form the M‐like image. The first deflec‐
tion is N75, which is negative. It is followed by a positive, sharper, and deeper wave, with a 
mean latency of 100 ms, that it is the P100. The third wave, N145, is also negative as the first 
one. However, the most important response is P100, because it is the most defined and the 
one that has greater reproducibility in normal people. It represents the occipital cortex depo‐
larization to the applied stimuli. The normal values for each one of these responses can vary 
in accordance with the laboratory and its equipment.
The first negative potential (N1) has a latency between 60 and 90 ms; the first positive poten‐
tial (P100) has a latency of 85–120 ms, with an average value of 100 ms. The second negative 
potential (N2) varies from 125 to 155 ms.
The amplitude of the P100 response varies between 3 and 21 μV. The amplitude of the N1 and 
N2 responses is a little lower and usually measures less than 12 μV for N1 and less than 16 μV 
for N2. N1 and N2 responses vary a lot, and in some cases, they are not easy to be identified. 
In part, for this reason, maximum attention is usually given to P100 response, which is easy to 
obtain and reproduce in normal people, and has well‐defined parameters.
P100 latency and the parameters of normality vary from a laboratory to another due to the tech‐
nique used, the type of equipment, and the age of the examined people. In laboratories where 
a population of young patients predominates, the mean and maximum latencies accepted as 
normal will be lower than those obtained in laboratories where older patients predominate.
The ideal is that each examining physician determines his/her own normal values. For this, at 
least 30 normal and representative people should be examined. The results obtained should 
be analyzed, and a mean latency should be determined for the whole group. The normal 
parameters are obtained, adding two or three standard deviations to this average value. If this 
is not possible, then normal values published by authors of high credibility in the area can be 
used in a more practical way.
As previously cited, the inconsistency and variability of the N1 and N2 potentials discour‐
aged most authors, and all the attention and importance was given to P100 response. Despite 
all this, Pavot believes that, although the N1 and N2 parameters are wider than those of P100, 
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there are certain limits of normality. According to his experience, in certain pathological con‐
ditions, as, for example, in multiple sclerosis (MS), in some cases the manifestations appear 
with an increase of N2 latency, or with its disappearance [14].
In the interpretation of the exams, absolute P100 latency is valued, as well as the difference 
between P100 latencies in one side and the other (interocular latency) and also its amplitude, 
which is compared with that of the contralateral eye. A difference of amplitude higher than 
50% between the two sides is significant.
2.3. Factors that interfere with the evoked visual responses
When performing VEP studies, it is extremely important to give much attention to some details 
that can affect the results. In addition to age, sex, visual acuity, and other physiological fac‐
tors, the visual evoked potentials are also affected by technical parameters, such as electrode 
positioning; luminosity in the examination room; level of concentration of the patient, who 
has to keep the look persistently directed to the center of the screen of the stimulation monitor; 
visual angle; luminosity and brightness of the monitor screen; and type of stimulator; filters.
In reversal pattern stimulation, variations in the quality of the stimuli, such as brightness, 
luminosity, frequency, and size of the square, can affect the responses, changing the morphol‐
ogy, amplitude, and latencies of its components.
Brightness reduction increases latency and reduces P100 amplitude, in 15 ms and 18%, respec‐
tively, for each log unit that reduces luminosity. The reduction of the contrast, which can be 
calculated in percentage according to the difference of luminosity between the white and 
black squares, also affects P100, increasing its latency and reducing its amplitude.
As previously mentioned, the size of the square determines the visual angle used and has direct 
influence in the responses. The use of smaller squares makes the study more accurate, but in 
turn, its use will depend on the level of visual acuity of the patient, since they stimulate the 
fovea, and the refractive defects produce out‐of‐focus retinal images, increasing P100 latency. 
The larger squares with up to 5 cm of side are less affected by the visual acuity variations.
The electrodes should be well located, because positioning them on points that are out of 
those normally proposed result in absent, or dispersed, responses with potentials of modified 
shapes, low amplitude, and unreal latencies. Loose, badly fixed electrodes produce artifacts 
that make the identification of the potentials difficult.
Noise excess in the room can affect the patient’s concentration capacity in the examination, 
making the look to deviate from the stimulator. During the examination, the examiner should 
ensure that the patient is kept awake all the time, and with the look focused on the center 
of the monitor screen. If the patient closes the eyes or deviates the look from the screen, the 
potential amplitude can lower and the latencies can increase, leading to false‐positive results.
In cases of restless patients, with concentration difficulty, as it is common to occur in children and 
even in those cases when the examiner suspects that the patient is purposefully trying to interfere 
with the examination, a stimulation performed with special glasses or goggles is recommended.
The Visual Evoked Potential in Idiopathic Inflammatory Demyelinating Diseases
http://dx.doi.org/10.5772/intechopen.69311
71
Some authors recommend to avoid exam performance in the evening because at this time the 
patient is frequently tired, sleepy and it is more difficult to remain concentrated, and with the 
look fixed on the screen.
Special attention should be given to refractive errors, and to retinal diseases. Patients who 
wear glasses or contact lenses have to be alerted to take them on the day of the examination, 
because decreased visual acuity slightly reduces amplitude of the responses, and can also 
change their latency.
Age modifies P100 latency, following a variable curve that is descending in the two first 
decades of life, steady until the fifth or sixth decade, and crescent above 60 years. Women 
tend to have little shorter latencies than men. However, menopausal women can present a 
higher P100 latency than men in a similar age.
In healthy individuals, there is no evidence of P100 alterations caused by the same increase 
of temperature or even by exercises. However, the exercises can reduce P100 amplitude in 
multiple sclerosis patients with impairment of the visual pathways [15].
3. Criteria for the analysis of the visual evoked potentials
In the analysis of the visual responses obtained, the examiner should value the following 
parameters: absolute latency; interocular latency difference, or interocular differential latency; 
P100 response amplitude; interocular amplitude difference or interocular differential ampli‐
tude; and potential morphology.
3.1. Absolute latency
The examiner evaluates whether the latency of the potential obtained is within the normal 
range, that is, the normal average with more or less three standard deviations. A latency that 
exceeds the limits of normality, with the possibilities of technical errors discarded, indicates a 
defect of sensory conduction in the studied visual pathway.
3.2. Interocular differential latency
The parameter for this measure should be determined in each laboratory, but in general it var‐
ies from 5 to 8 ms. An interocular differential latency above these values is usually associated 
with pathologies. Many times this latency increase is the first manifestation of some diseases. 
In many cases of optic neuritis, the interocular latency change can be the only abnormality 
detected.
3.3. P100 response amplitude
P100 amplitude can vary in normal people, but an amplitude of 1–5 μV, or the absence of P100 
generally means a pathological condition [16].
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3.4. Interocular amplitude difference
There is much controversy on the limit of normality for the value of the amplitude differ‐
ence between the responses obtained in the two eyes. When the stimulation for the “full‐
field reversal pattern” is used, some authors advocate that, to be abnormal, there must be an 
amplitude reduction of at least 80%, or total absence of P100. However, for most authors, a 
reduction of the differential amplitude between 50 and 75% or more indicates visual pathway 
impairment. In the stimulation of the hemifield, there is a consensus that an amplitude differ‐
ence of more than 50% is abnormal.
3.5. Morphology
In a normal person, the P100 response has the format of a letter “V.” An alteration in the 
potential shape or its disappearance represents an abnormality [16].
4. Clinical applications
Any pathology, regardless of its nature, which affects the ocular structures responsible for the 
reception of light and images, the visual pathway, or the cortex, can lead to changes in the 
visual evoked responses. In the pure retinal pathologies, as it occurs in the retinitis pigmen‐
tosa, the important changes in the ophthalmologic examination and in the electroretinogram 
are very striking and easy to be identified. On the other hand, it is important to remember that 
retinal responses take a long time to disappear in cases of brain death.
In the diseases affecting the receptors and the visual pathways, or the visual pathways and 
the cortex, frames with coincident or divergent findings can be observed in the VEP studies. 
The frames known as coincident are those in which no difference in the type of response 
obtained is observed, either with the use of the flash, or with the reversal pattern, that is, the 
responses are normal or abnormal in the two methods. In the frames with divergent findings, 
the neurophysiological abnormalities are manifested in only one of the techniques, with nor‐
mal responses being observed in the other.
The visual evoked potentials are used in the investigation of neurological impairment, mainly 
in the suspicion of optic neuritis, multiple sclerosis, and compressive lesions affecting the 
visual pathways. Diseases affecting the optic nerve or causing its demyelination are the more 
frequently associated with changes of visual response latency. To understand the neurophysi‐
ological diagnosis, and the alterations caused by pathologies throughout the optic pathways, 
it is necessary to know these pathways anatomy [17, 18].
The visual pathways are formed from the retina, through the chaining of three types of neu‐
rons. The first receptor neurons, which are the cones and the rods, make synapsis with bipolar 
cells, and these ones with a third type of neuron, which are the ganglion cells. The ganglion 
cell axon junction forms the optic nerves, which take the visual impulses to the lateral genicu‐
late bodies in the diencephalon, where they make synapses with neurons that go to the occipi‐
tal cortex through the geniculocalcarine tract.
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In its route to the geniculate bodies, the optic nerve fibers from the nasal portion of each retina 
cross to the opposite side on the level of the optic chiasm. Thus, from the chiasm, each optic 
tract consists of the optic fibers from the temporal retina on the same side and of the fibers 
that were formed in the contralateral nasal retina. This peculiarity of the optic pathways to 
cross part of their fibers in the chiasm, continuing as a mixed tract that has fibers of the retinal 
portion of the ipsilateral eye, and also of the contralateral eye, causes the most varied visual 
syndromes, depending on the location of the lesion.
5. CNS idiopathic inflammatory demyelinating diseases
Demyelinating optic neuritis represents the most frequent cause of transitory visual loss in 
young adults, affecting 2.6 men and 7.5 women per year, for each 100,000 inhabitants. The 
average age for its occurrence is 31 years. The optic pathway demyelination causes blocks 
or delays in the visual pathways conduction, with consequent alterations in the studies of 
visual evoked potentials. Demyelination precedes the inflammatory process, which is the real 
responsible for the reversibility of the picture. Thus, inflammation improvement contributes 
for the rapid visual improvement after a crisis. In addition, mainly in young people, remyelin‐
ation is another important factor in the recovery of vision. However, when an axonal lesion 
and a more persistent demyelination occur, improvement is not usually complete.
Visual loss in optic neuritis can be preceded in some days by ocular pain in the affected side, 
which tends to resolve. This pain is possibly caused by the tension on the inflamed nerve. 
About 70% of the adults initially present with a unilateral picture, but in 30% it can affect both 
eyes. The visual loss can be sudden, progressing in a few hours, or can have a slower progres‐
sion, taking some days to be installed. In 7% of the cases, this time is of 1–2 weeks.
The diagnosis of optic neuritis is one of exclusion, what makes the investigation of other dis‐
eases affecting the optic nerve, such as hereditary, metabolic, toxic, vascular, and compressive 
diseases, indispensable.
In the isolated demyelinating optic neuritis, the magnetic resonance reveals changes on the affected 
nerve in 84% of the cases. In 34% of the patients, the exam also shows changes in the asymp‐
tomatic side. In addition, 50–70% of these patients show multifocal demyelinating lesions in the 
corpus callosum and on the periventricular white substance or in other parts of the encephalon.
Within the group of the idiopathic inflammatory demyelinating diseases, there is a great num‐
ber of pathologies that can have an initial outbreak in common, either visual, motor, sensitive, 
proprioceptive, cerebellar, medullary or of the brainstem, characterizing the so‐called clinically 
isolated syndrome—CIS. It is only after the second outbreak and evaluation of the comple‐
mentary exams that it is possible to establish or suggest the definitive diagnosis, such as MS. 
This aspect can sometimes confuse physicians who attend the patient and delay the treatment.
MS diagnosis is based on the identification, at history taking, of two acute episodes with a 
duration of at least 24 h, and evidence at the neurological examination of objective signs of 
functional system impairment, indicating inflammatory lesions located on different topogra‐
phies in the CNS.
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It was only in 1983 that complementary methods, such as magnetic resonance and evoked 
potentials, were introduced in the MS diagnosis criteria proposed by Poser, with the pur‐
pose to identify subclinic inflammatory lesions. In the last decade, MRI was used to confirm 
temporal and spatial dissemination of inflammatory lesions in the neuroaxis and then to 
anticipate the clinical diagnosis of MS. Currently, with a patient with monofocal or multifo‐
cal clinically isolated syndrome, the dissemination in the space can be demonstrated in the 
MRI through T2 hyperintense lesions, in at least two of the four regions of the CNS: periven‐
tricular, juxtacortical, infratentorial, and spinal. Temporal dissemination is proven by the 
presence of a new T2 lesion, or a contrast‐enhancing lesion, when serial MRI scans are com‐
pared, or by the coexistence of asymptomatic contrast‐enhancing or nonenhancing lesions 
in a single initial examination. These radiological criteria should only be applied to young 
patients, with strong clinical suspicion of MS characterized by the presence of clinical signs 
of acute CNS impairment, which presents with outbreaks, having a suggestive behavior of 
an inflammatory disease, and after ruling out all the diseases secondarily affecting the white 
substance. The application of these criteria aims to anticipate the clinical diagnosis and, con‐
sequently, the beginning of the treatment, since all the FDA‐approved medicines from 1993 
on for MS act in the initial phase of the disease, reducing inflammation and the annual rate 
of outbreaks [20].
MS is a chronic disease, with greatly variable prevalence and incidence, dependent on ethnic‐
ity and demographic region, with the highest indices being described in Caucasian popula‐
tions living in regions of the North hemisphere, places of cold weather. In its more prevalent 
clinical form, there are outbreaks and remissions that affect individuals from 20 to 40 years 
of age, and with predominance in women. Currently, it is estimated that more than 300,000 
Americans have a definite diagnosis of the disease and, because it affects young patients in 
full activity, it has strong sociocultural impact [21].
NOM, which was included among MS variants, is currently considered an independent con‐
dition. The historical description of this disease was a clinical, and anatomical and pathologi‐
cal case report in 1894, in France, by Eugene Devic. This condition was called Devic’s disease, 
and during a century, the diagnosis was based on the identification of an acute, monopha‐
sic inflammatory disease, characterized by severe and bilateral ON, and transverse myelitis 
(TM), installed simultaneously or in a short interval of time. Only after the 1990s studies of 
independent series published in different western and eastern populations started to describe 
recurrent cases of NOM, where the index events occurred separately for a variable period of 
time, and were followed by new acute episodes, affecting the spinal cord and the optic nerve 
[22–24]. Only recently the presence of lesions in locations other than the spinal optic axis was 
accepted, with inflammatory lesions being demonstrated, although in lower frequency, in the 
brainstem and encephalon [23]. In Asian individuals, the selective and severe involvement 
of the optic nerves and spinal cord is very typical. In this region, this syndrome is classified 
as a variant of MS, defining two distinct subtypes: the opticospinal form (OSMS), which has 
characteristics that are similar to the remittent‐recurrent form of western NOM, and the con‐
ventional form, which is similar to the classic MS, as it is described in western patients [25].
Currently, many works in the literature try to define the probability of an isolated and 
initial case of idiopathic optic neurite to progress, to keep its monophasic course, to be 
The Visual Evoked Potential in Idiopathic Inflammatory Demyelinating Diseases
http://dx.doi.org/10.5772/intechopen.69311
75
associated with myelitis or with outbreaks that impair other areas of the CNS. Among 
several significant aspects, the main justifications for these studies regarding the progres‐
sion risk are related to the patient’s prognosis, and the possibility to search early therapies 
at the first signs of isolated idiopathic ON, since this can be the first symptom, not only of 
NOM, but also of MS.
The clinical and evolutive characteristics of idiopathic ON have been analyzed by the Optic 
Neuritis Study Group (1995). The most relevant predictive factor of MS development after 
15 years was the presence of changes in the brain MRI in the occasion of a visual outbreak 
[26]. Other works tried to identify the main characteristics of the cases of NOM‐related 
ON, evidencing that in this condition the visual involvement is generally more severe and 
bilateral [24].
In 2007, Wingerchuk et al. [27], from the Mayo Clinic, defined a group of conditions that were 
catalogued as syndromes of the NOM spectrum. These entities, although independent, are 
elements of the same group. They are as follows: neuromyelitis optica (NOM), extensive idio‐
pathic myelitis, recurrent monocular optic neuritis (rON) or simultaneously bilateral optic 
neuritis (BON), Asian‐type opticospinal multiple sclerosis (OSMS), optic neuritis, or extensive 
idiopathic myelitis associated with systemic autoimmune disease, optic neuritis, or idiopathic 
myelitis associated with typical brain lesions of NOM (hypothalamus, corpus callosum, and 
periventricular region) or lesions in the brainstem.
6. VEP in idiopathic inflammatory demyelinating diseases
Since 1972, the pattern of visual response abnormalities of patients with ON, obtained with 
this method, has been studied [28], with the MS‐related VEP characteristics of the optic neu‐
ritis being well‐defined. However, there are few articles in the literature discussing the VEP 
pattern in NOM. Currently, MS pattern is frequently used to analyze the VEP of patients with 
NOM, configuring an interpretation bias.
The most common changes in the VEP studies in MS, in descending order of prevalence and 
importance, are as follows: the absolute increase of P100 wave latency, this wave morphology 
changes, and finally the absence of response. Frederiksen and Petrera [29] followed patients 
in the acute phase of ON since the beginning of the symptoms, with performance of VEP, 
repeating it in subsequent months. Among these patients, 35.5% had the definite diagnosis of 
MS, and had, according to the authors, a significant relation with delays of P100 wave latency 
in the VEP. They also observed subclinical changes of the optic nerve, with the presence of 
abnormal VEP in asymptomatic eyes.
Several studies emphasize VEP sensitivity in the evaluation of ON in patients with demyelin‐
ating diseases, even overcoming the optical coherence tomography, as Naismith et al. showed 
in 2009 [30]. At that time, the authors evaluated patients with different diagnosis related to 
the demyelinating diseases (CIS, MS, and NOM) that had at least one episode of ON in the 
last six months and tried to compare VEP sensitivity to the optical coherence tomography, 
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in the evaluation of clinical and subclinical ON. VEP showed higher sensitivity both in the 
evaluation of clinically identified ON (81% vs. 60%, p = 0.002), and in the cases of evaluation 
of asymptomatic eyes.
In the study by Matthews et al. [29], a total of 223 individuals were evaluated, with 186 with 
a diagnosis of MS and 37 healthy controls. In this study, the sample was submitted to VEP, 
to evaluate the differences in the pattern of responses to this exam, considering the groups of 
definite, probable, possible MS, and the control group. It showed that while all controls had 
VEP responses within normal range, the group with definite MS had a higher percentage of 
change when compared to the other groups. It was also observed that the main characteristic 
of the VEP that was changed was P100 wave latency in these patients.
Frederiksen and Petrera [31] followed patients in the acute phase of ON since the beginning of 
symptoms, with performance of VEP, and its repetition in subsequent months. Among these 
patients, 35.5% had definite diagnosis of MS, and had, according to the authors, a significant 
relation with delays of P100 wave latency in the VEP. They also observed subclinical changes 
of the optic nerve, with the presence of abnormal VEP in asymptomatic eyes.
In order to enhance the sensitivity for the detection of optic nerve affections with the use of 
VEP, and to analyze its effectiveness in the early evaluation of patients with suggestive pic‐
tures of ON and MS, Davidson et al. in 2004 [32] examined 124 individuals with VEP using 
two different intensities of contrast. Although they observed a higher number of abnormal 
VEP with reduced contrast, when they followed the outcome they noticed that they were false 
positives.
Considering that NOM is a pathology that is different from MS, and its strong relation with 
the presence of anti‐AQP4 serum antibodies, Watanabe et al., in 2009 [33], decided to study 
the abnormalities of the findings of evoked potentials of patients with definite diagnosis of 
MS, and the presence of positivity for anti‐QP4. In this study, they observe that in the anti‐
QP4‐negative MS group the delay in the latency of the P100 wave is evident, following the lit‐
erature. However, the anti‐QP4‐positive group presents a higher percentage of patients with 
absence of this wave, revealing a more severe lesion (p = 0.003). They also conclude that the 
antibody positivity, and the absence of response, showed significant relation with a more seri‐
ous progression of visual impairment (OR = 35.432%, p < 0.001).
Naismith et al., in 2009, evaluated patients with different diagnoses related to demyelinating 
diseases (CIS, MS, and NOM) that had at least one episode of ON in the last 6 months and 
tried to compare VEP sensitivity with the optic coherence tomography in the evaluation of 
clinical and subclinical ON. VEP showed higher sensitivity both in the evaluation of clinically 
identified ON (81% vs. 60%, p = 0.002) and in the cases of evaluation of asymptomatic eyes 
(75% vs. <20%) [34].
Neto et al., in 2013, conducted a study where 19 patients, with NOM diagnosis, with 74% 
being Afro‐Brazilians, underwent VEP study. Of the 38 eyes examined, 18 (47.37%) showed 
no visual evocable response. Of the 20 eyes (52.63%) where VEP responses were detected, 18 
(90%) had P100 wave latency within normal range, while only 2 (10%) had increase of the 
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latency of this wave. Regarding P100 wave amplitude, 11 of the 20 eyes (65%) that generated 
visual responses had values below that considered normal in the study. Seven (35%) had 
amplitudes ≥ 5.8 μV, being considered normal. In 65% of the 20 eyes where the visual response 
was evocable, a reduction of the P100 wave amplitude was found, with normal latency [34].
Ringelstein et al., in 2014, reproduced the study by Neto et al., and analyzed the medical 
records of 43 Caucasian patients with NOM diagnosis, and compared the findings of their 
VEP with those of 81 healthy patients. The authors find reduced amplitude in 12.3%, long 
latencies in 41.9%, and absence of response in 14% of NOM eyes, suggesting that VEP in NOM 
would have a heterogeneous standard. However, the frequencies of amplitude reduction and 
the absence of response are greater than those observed in all the studies of patients with MS. 
In the article, they suggest that the difference in sample results, compared to the study by 
Neto et al. could be explained by ethnic issues that distinguish the populations studied [19]. 
In addition, in the study by Ringelstein et al., the reference value for amplitude normality is 
lower than that used by Neto et al., being 3.0 and 5.8 μV, respectively [35].
In 2015, Chirapapaisan et al. evaluated hospital medical records of patients being investi‐
gated for MS, with no definite diagnosis. VEP was analyzed, along with the confirmation of 
the subsequent diagnosis of MS through McDonald diagnostic criteria (2005). Twelve of the 
35 patients (34%) converted to MS, and 23 (66%) did not have diagnostic confirmation. P100 
Latencies and differences of interocular latency were longer in the clinically definitive MS 
(CDMS) than in non‐CDMS patients (p = 0.002, 0.001, respectively). All patients of the group 
that converted to MS had P100 latencies higher than 102ms, the average of the patients with 
no diagnosis of MS, thus providing 100% of sensitivity. No patient developed MS with P100 
latency <102 ms. Brain lesions in the magnetic resonance were significantly associated with 
CDMS development (p = 0.001). Therefore, the previsibility to develop CDMS was higher 
when the P100 latency delay and the brain lesions of magnetic resonance were concomitantly 
present [36].
In the last decade, recurrent ON, not associated with MS and NOM, was classified according 
to its clinical presentation in recurrent isolated form (RION) and chronic recurrent (CRION) 
form [37]. In CRION and RION, ON is more severe than in MS, leading to severe, bilateral 
visual impairment that can cause amaurosis. However, while a high prevalence of anti‐AQP4 
antibody positivity is observed in NOM, in CRION 95% of the patients present negativity for 
anti‐AQP4 [38]. In all syndromes cited, the OCT reveals significant reduction of the fiber lay‐
ers of the temporal and nasal retina.
7. Conclusions
We can conclude that VEP has recently been sufficiently studied and shows differences 
between the classic pattern of MS and that of NOM, where the responses are more hetero‐
geneous, and the reduction of P100 wave amplitude and the absence of response are more 
prevalent [34], but data in the literature are lacking about the VEP pattern in RION, CRION, 
syndromes of the NOM spectrum, and OSMS of MS.
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